Hypermarcas (OTCMKTS:HYPMY) Short Interest Down 94.7% in May

Hypermarcas (OTCMKTS:HYPMY) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totaling 3,352 shares, a decrease of 94.7% from the April 30th total of 63,443 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 57,615 shares, the days-to-cover ratio is presently 0.1 days.

Hypermarcas Stock Up 0.5%

Shares of HYPMY stock traded up $0.02 on Wednesday, reaching $4.41. 23,637 shares of the company were exchanged, compared to its average volume of 35,697. The company has a market cap of $3.10 billion, a price-to-earnings ratio of 9.19 and a beta of 0.73. The company has a 50-day moving average of $4.53 and a 200-day moving average of $4.51. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84. Hypermarcas has a one year low of $3.71 and a one year high of $5.50.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. The company had revenue of $383.13 million for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. Analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Hypermarcas has an average rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.